Alnylam Pharmaceuticals, Inc. (ALNY) operating KPIs

ALNYNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 7/30

$165.00−9.00 (-5.17%)

Close on Oct 30, 2026Market cap $22.08BP/E –Yield –

KPIs

Operating metrics that drive Alnylam Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to Alnylam Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.